Dark

CBIO
Crescent Biopharma, Inc. Common Stock
stock NASDAQ

At Close

Sep 25, 2026 3:59:45 PM EDT

13.98USD-1.826%(-0.26)228,685

13.86Bid 16.23Ask 2.37Spread

Pre-market

Sep 24, 2026 9:02:30 AM EDT

14.00USD-1.685%(-0.24)0

After-hours

Sep 25, 2026 4:02:30 PM EDT

14.23USD+1.788%(+0.25)175

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

520.89M

CEO

Nassim Usman

Headquarters

South San Francisco, California, USA

Industry

Biotechnology

Next Earnings

Nov 5, 2026 (41d)

Last Dividend

Aug 20, 20151.649

Last Split

Jun 16, 20251for100reverse

CORT AZN BMY JNJ PFE MRK ABBV ADMS ZGNX XLV

CBIO Stats

Avg. Vol. 10 Day

712,180

Avg. Vol. 30 Day

414,724

Employees

Market Cap

520,891,424

Shares Out.

37,146,830

On/Off Exchange

58%/42%

6 Month Beta

1.09

1 Year Beta

0.88

2 Year Beta

1.01

3 Year Beta

1.15

52 Week Low

8.72

52 Week High

27.41

SMA50

16.99

SMA200

15.72

1 Week

-16.98%

1 Month

-17.52%

3 Month

-17.47%

6 Month

+19.04%

1 Year

+12.99%

2 Year

-11.22%

5 Year

-80.28%

Profile

catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.

CBIO Stock Summary

Crescent Biopharma, Inc. Common Stock (NASDAQ:CBIO) stock price today is $13.98, and today's volume is 228,685. CBIO is down -1.826% today. The 30 day average volume is 414,724. CBIO market cap is 520.89M with 37,146,830 shares outstanding.